Mr Roy Matison White Jr, MD | |
2211 E Northern Lights Blvd, Anchorage, AK 99508-4103 | |
(907) 279-8486 | |
(907) 257-8180 |
Full Name | Mr Roy Matison White Jr |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 53 Years |
Location | 2211 E Northern Lights Blvd, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023180114 | NPI | - | NPPES |
MD1170 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 1170 (Alaska) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Park Family Care Inc | 9638161268 | 25 |
News Archive
The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.
As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a new ray of hope is emerging from a surprising place: the testing side of the equation.
Sosei Group Corporation, announces that results reported today by Novartis from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237 50 mcg significantly improved lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) relative to placebo, with similar efficacy to open-label tiotropium.
A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease.
› Verified 5 days ago
Entity Name | Medical Park Family Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144392317 PECOS PAC ID: 9638161268 Enrollment ID: O20040401001357 |
News Archive
The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.
As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a new ray of hope is emerging from a surprising place: the testing side of the equation.
Sosei Group Corporation, announces that results reported today by Novartis from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237 50 mcg significantly improved lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) relative to placebo, with similar efficacy to open-label tiotropium.
A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Roy Matison White Jr, MD 2211 E Northern Lights Blvd, Anchorage, AK 99508-4103 Ph: (907) 279-8486 | Mr Roy Matison White Jr, MD 2211 E Northern Lights Blvd, Anchorage, AK 99508-4103 Ph: (907) 279-8486 |
News Archive
The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.
As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a new ray of hope is emerging from a surprising place: the testing side of the equation.
Sosei Group Corporation, announces that results reported today by Novartis from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237 50 mcg significantly improved lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) relative to placebo, with similar efficacy to open-label tiotropium.
A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease.
› Verified 5 days ago
Candace L Clawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1624 Fax: 907-729-1634 | |
Dr. William Murray Buttner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-561-4806 | |
Robert L Mcalister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-2992 | |
Shane W Cummings, M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515 Phone: 907-344-2400 Fax: 907-344-2404 | |
Jeremy D Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Compassion Cir, Anchorage, AK 99504 Phone: 907-212-9200 Fax: 907-212-9283 | |
Kelton Hillard Oliver, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12302 Woodward Dr, Anchorage, AK 99516 Phone: 907-580-0002 | |
Ryan T. Mcwilliams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508 Phone: 907-729-6321 |